Eli Lilly
LLY
$425.79
Share price
-0.36%
Change (1 day)
35.84%
Change (1 year)
Categories
With over 33,000 employees worldwide, production plants in 13 countries and annual sales of over $22 billion worldwide, Eli Lilly and Company is one of the largest pharmaceutical companies in the world. It was founded in Indianapolis in 1876 by the pharmacologist, officer and entrepreneur Eli Lilly.
Eli Lilly (LLY) - P/B ratio
P/B ratio as of May 2023 : 35.8
According to Eli Lilly's latest financial reports the company has a price-to-book ratio of 35.8.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Eli Lilly - P/B ratio (from 2001 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 32.3 | 11.77% |
| 2021-12-31 | 28.9 | 4.1% |
| 2020-12-31 | 27.7 | -40.54% |
| 2019-12-31 | 46.6 | 315.59% |
| 2018-12-31 | 11.2 | 40.76% |
| 2017-12-31 | 7.97 | 38.22% |
| 2016-12-31 | 5.77 | -9.66% |
| 2015-12-31 | 6.38 | 28.19% |
| 2014-12-31 | 4.98 | 54.22% |
| 2013-12-31 | 3.23 | -15.64% |
| 2012-12-31 | 3.83 | 7.67% |
| 2011-12-31 | 3.55 | 9.29% |
| 2010-12-31 | 3.25 | -24.49% |
| 2009-12-31 | 4.31 | -36.63% |
| 2008-12-31 | 6.80 | 53.38% |
| 2007-12-31 | 4.43 | -17.46% |
| 2006-12-31 | 5.37 | -9.39% |
| 2005-12-31 | 5.93 | 0.74% |
| 2004-12-31 | 5.88 | -27.32% |
| 2003-12-31 | 8.09 | -6.05% |
| 2002-12-31 | 8.61 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.22 | -85.41% | 🇺🇸 USA |
 Novartis NVS | 3.98 | -88.88% | 🇨🇭 Switzerland |
 Pfizer PFE | 2.21 | -93.82% | 🇺🇸 USA |
 AbbVie ABBV | 14.0 | -60.77% | 🇺🇸 USA |
 Amgen AMGN | 21.7 | -39.43% | 🇺🇸 USA |
 Sanofi SNY | 1.65 | -95.38% | 🇫🇷 France |
 Merck MRK | 6.12 | -82.90% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 4.20 | -88.25% | 🇺🇸 USA |
 AstraZeneca AZN | 6.28 | -82.45% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 5.00 | -86.01% | 🇬🇧 UK |